2009 TAPITMAT Award Recipients
We are delighted to announce the third round of successful applications for the Institute for Translational Medicine and Therapeutics’ (ITMAT) Transdisciplinary Award Program (TAPITMAT), supported by the School of Medicine. The quality of all applications was extremely high and the funding decisions, made by members of the Internal Advisory Board, were extremely difficult.
The selected projects range across the breadth of biology, integrate diverse disciplines and investigators from many schools of Penn, the Wistar Institute, and the University of the Sciences in Philadelphia reflecting their interaction in the context of the Clinical and Translational Science Award. They are uniformly of high scientific quality, interdisciplinary and translational in nature.
ITMAT is delighted with the number and quality of applications responsive to this call for awards and will continue to develop the program further in future years for awards and hopes to develop the program further in future years.
Michal Elovitz, MD, Department of Obstetrics and Gyencology, School of Medicine
Edward Brodkin, MD,, Department of Psychiatry, School of Medicine
Exposure to prenatal inflammation and adverse neurobehavioral outcomes
Khurana Tejvir, MD, PhD, Department of Physiology, School of Medicine
Samuel Lamitina, PhD, Department of Physiology, School of Medicine
Paola Arratia, PhD, Department of Mechanical Engineering and Applied Mechanics, School of Engineering and Applied Sciences
Development of a Novel Therapeutic Strategy for Limb Girdle Muscular Dystrophy (LGMD2B)
John Maris, MD, Department of Pediatrics, School of Medicine
Mark Lemmon, PhD, Department of Biochemistry and Biophysics, School of Medicine
Yael Mosse, MD, Department of Pediatrics, School of Medicine
Structural basis for ALK inhibition therapies
Harvey Rubin, MD, Department of Medicine, School of Medicine
Jeffrey Winkler, PhD, Department of Chemistry, School of Arts and Sciences
Development of New Antibiotics against Mycobacterium tuberculosis based on the Oxidative Phosphorylation System
Wenchao Song, PhD, Department of Pharmacology, School of Medicine
Zhijun Li. PhD, Department of Chemistry and Biochemistry, University of the Sciences in Philadelphia
Development of small molecule inhibitors of human complement factor B
Robert Wilson, MD, PhD, Depatment of Pathology and Laboratory Medicine, School of Medicine
Amos Smith, PhD, Department of Chemistry. School of Arts and Sciences
Donna Huryn, PhD, Department of Chemistry. School of Arts and Sciences
Therapeutic Development for Friedreich Ataxia
For more information, please visit our website at http://www.itmat.upenn.edu.
Garret A. FitzGerald, MD